Family Medicine · Ashland, AL
NPI
1497780761
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
83745 Highway 9 Ste B
Ashland, AL, 36251
Phone (256) 354-4142
Groups this clinician bills Medicare through
Medicare paid, 2024
$140K
11,887 services
Medicare patients, 2024
359
Average age 75
Drug cost, 2024
$2.0M
24,466 prescriptions
Company payments, 2025
$459
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John S Fischer was code J1010 (injection, methylprednisolone acetate, 1 mg), 8,512 times for 103 patients. In total John S Fischer billed 11,887 services in 95 codes, and Medicare paid $140K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 8,512 | 103 | $0.09 | $730 |
| 99214 Office E&M - Established | Office | 754 | 265 | $73.08 | $55K |
| 96372 Injection Administration | Office | 328 | 156 | $8.84 | $2,901 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 205 | 205 | $23.47 | $4,812 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 183 | 183 | $119.35 | $22K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 183 | 183 | $17.01 | $3,113 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 176 | 57 | $0.08 | $13.55 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 130 | 47 | $0.31 | $39.74 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 118 | 36 | $0.49 | $57.96 |
| 81002 Clinical Chemistry | Office | 114 | 66 | $3.41 | $389 |
| 99232 Hospital E&M - Subsequent | Facility | 88 | 51 | $58.35 | $5,135 |
| 99308 SNF E&M | Facility | 87 | 16 | $38.58 | $3,357 |
| G0008 Administration of influenza virus vaccine | Office | 74 | 74 | $29.46 | $2,180 |
| 90662 Vaccine Product | Office | 70 | 70 | $77.73 | $5,441 |
| 99213 Office E&M - Established | Office | 64 | 58 | $47.23 | $3,022 |
By year: 2022 $144K for 3,800 services; 2023 $137K for 3,480 services; 2024 $140K for 11,887 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 114 | 66 | $3.41 | $389 |
| 87426 Immunoassay | 53 | 43 | $34.06 | $1,805 |
| 87804 Immunoassay | 52 | 25 | $15.78 | $821 |
| 36415 Venipuncture Blood Collection | 46 | 41 | $8.65 | $398 |
| 87631 Infectious Agent Detection by DNA/RNA | 25 | 24 | $139.78 | $3,495 |
Medicare prescription drug claims, 2024
In 2024, the drug John S Fischer prescribed most often to Medicare patients was Rosuvastatin Calcium, with 741 prescriptions and refills. In total John S Fischer wrote 24,466 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 741 | 1,836 | 203 | $10K |
| Levothyroxine Sodium Generic | 721 | 1,525 | 151 | $7,900 |
| Metoprolol Succinate Generic | 621 | 1,407 | 170 | $11K |
| Gabapentin Generic | 618 | 659 | 122 | $4,579 |
| Omeprazole Generic | 595 | 1,385 | 172 | $9,047 |
| Amlodipine Besylate Generic | 558 | 1,333 | 155 | $4,044 |
| Furosemide Generic | 552 | 1,003 | 144 | $2,129 |
| Atorvastatin Calcium Generic | 521 | 1,264 | 138 | $6,983 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 519 | 520 | 84 | $7,834 |
| Meloxicam Generic | 485 | 763 | 133 | $1,871 |
| Potassium Chloride Generic | 423 | 742 | 103 | $5,023 |
| Eliquis Apixaban | 405 | 506 | 58 | $247K |
| Levocetirizine Dihydrochloride Generic | 400 | 571 | 105 | $3,957 |
| Tramadol Hcl Generic | 384 | 384 | 84 | $1,985 |
| Quetiapine Fumarate Generic | 351 | 451 | 54 | $3,445 |
Brand drugs: 2,907 claims; generic drugs: 21,388 claims; opioid claims: 1,204.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John S Fischer $459 ($459 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $180.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 11 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $71.15 |
| Novo Nordisk Inc NVO | 3 | $53.13 |
| Dexcom, Inc. DXCM | 1 | $32.9 |
| Exact Sciences Corporation EXAS | 2 | $31.67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29.52 |
| GlaxoSmithKline, LLC. GSK | 2 | $28.58 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $17.64 |
| Amgen Inc. AMGN | 1 | $14.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.